Recent news on Ramelteon

Ramelteon does not impair balance, mobility or memory performance ...  -  25 May 2007
News-Medical.net,A new study shows that ramelteon did not impair middle-of-the-night balance, mobility or memory performance in older adults with insomnia,

Takeda Submits a European Marketing Authorization Application for ...  -  Mar 20, 2007
PharmaLive.com (press release),This mechanism of action of ramelteon is different from existing insomnia treatments, which work by depressing the central nervous system (CNS).

Pharma Sector: Few Newsmakers Of The Week - AtheroGenics, Pain ...  -  Mar 24, 2007
Trading Markets,Ltd., based in Japan, filed its application with the European Medicines Agency, seeking marketing approval for insomnia drug ramelteon.

Japan's Takeda seeking European approval for insomnia drug  -  Mar 20, 2007
MarketWatch...said Tuesday it has applied for marketing approval for its "Ramelteon" insomnia drug to the European Medicines Agency.

Takeda seeks approval for sleep drug in Europe  -  Mar 20, 2007
ReutersTakeda said it has submitted a marketing application to the European Medicines Agency for the insomnia drug, Ramelteon, which is already being sold in the

Fujitsu, Sumitomo Osaka, Mizuho, Toyota: Japan Equity Preview  -  Mar 20, 2007
BloombergTakeda applied to the European Medicines Agency for marketing approval for the drug, which has the generic name Ramelteon, it said in a statement.

FDA Strengthens Warnings on Sleep Drugs  -  Mar 15, 2007
Medscape (subscription)Tyco Healthcare); ramelteon tablets (Rozerem, Takeda); seconal sodium capsules (Ranbaxy); and zaleplon capsules (Sonata, King Pharmaceuticals).

FDA Warns of Sedative-Aided Sleep Driving and Anaphylaxis  -  Mar 14, 2007
MedPage Today,He said the FDA's action was triggered by two events-reports of "angioedema in the wake of the most recently approved hypnotic (ramelteon [Roserem])" and

Label Change Requested for All Sleep Disorder Drugs  -  Mar 14, 2007
Facts and Comparisons,Restoril (temazepam), Rozerem (ramelteon), Sonata (zaleplon), Carbrital (pentobarbital/carbromal), Placidyl (ethchlorvynol), and Seconal (secobarbital).

Takeda Pulls Sleeping-Pill TV Ad After FDA Warning (Update4)  -  Mar 8, 2007
BloombergRozerem, whose generic name is ramelteon, has not been studied in children or adolescents, according to drug-safety information posted on the Rozerem Web

FDA Sends Letter to Takeda Over Rozerem Advertisement  -  Mar 9, 2007
PharmaLive.com (press release),...(DTC) television advertisement (TV ad) for Rozerem (ramelteon) Tablets (Rozerem) disseminated by Takeda Pharmaceuticals North America, Inc. (Takeda).

Restless Leg Syndrome  -  Mar 7, 2007
KKTV 11 News,Commonly used sedatives for RLS include clonazepam (Klonopin), eszopiclone (Lunesta), ramelteon (Rozerem), temazepam (Restoril, Razapam), zaleplon (Sonata)

Melatonin as an anti-aging therapeutic for the brain  -  Feb 9, 2007
Methuselah Foundation,The drug, ramelteon, is marketed as Rozerem (via an incomprehensible campaign involving Abraham Lincoln and a beaver). Intriguing possibility: If melatonin

Sales strong for Takeda but pressure to expand is on  -  Feb 1, 2007
Pharma Times (subscription),New products Rozerem (ramelteon) for sleeping disorders, which was launched in the USA in September 2005, and Amitiza (lubiprostone) for constipation which

Organon is excited about new insomnia drug  -  Dec 20, 2006
Pharma Times (subscription),...one and it would be competing against the likes of Takeda's Rozerem (ramelteon), Sanofi-Aventis' Ambien (zolpidem) and Sepracor's Lunesta (eszopiclone).

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)...has not included a restriction limiting treatment of insomnia to short-term use for the last three agents it has approved (eszopiclone, ramelteon, and zolpidem ...

Organon is excited about new insomnia drug  -  Dec 20, 2006
Pharma Times (subscription),...$1 billion euros if approved but the insomnia market is a tough one and it would be competing against the likes of Takeda's Rozerem (ramelteon), Sanofi-Aventis ...

Sleep with Rozerem medication  -  Nov 27, 2006
Free press releases (press release),Rozerem with the active ingredient of Ramelteon has been found working effectively to treat insomnia amongst adults. Rozerem that ...

Effects Of New Sleep Medication Appear Unlikely To Have Potential ...  Oct 12, 2006
In a study of 14 adults with histories of sedative abuse, the newly approved sleep medication ramelteon does not appear to have effects that indicate potential ... -Science Daily (press release) New Sleeping Pill Unlikely To Be Abused  Oct 12, 2006
New York, NY (AHN)-Researchers note that a new medication, Rozerem (known generically as ramelteon), recently approved for insomnia treatment does not appear ... -All Headline News Benzer11.com comes up with sleep aids not to be overused  Oct 26, 2006
Rozerem had no significant effects on cognition or movement control and no apparent potential for abuse, and the fact is that rozerem (ramelteon) at its ... -Free press releases (press release), New sleeping pill not likely to be overused  Oct 12, 2006
The sleep aid, Rozerem (known generically as ramelteon), acts in the same way as melatonin, the natural hormone that has been linked to healthy sleep in ... -Scientific American Rozerem found to have no drug abuse  Oct 12, 2006
They received different doses of: ramelteon (16, 80 or 160 milligrams); the benzodiazepine receptor agonist triazolam/Halcion (0.25, 0.5 or .75 milligrams ... -Free press releases (press release), Healthcare: FH Remedy wins Takeda Euro job  Oct 20, 2006
...work on medical meetings to support Actos (pioglitzone), Blopress (candesartan) and leuprorelin, but includes meetings for pre-launch insomnia drug ramelteon. ... -Therapeutics Daily (subscription) (press release), Fall Back--Into Bed  Oct 19, 2006
...however. A new prescription sleep medication, Ramelteon, which works by mimicking melatonin, also may be worth a try, Sassower says. ... -Forbes, Unfavorable Tier Placement Makes Safer Insomnia Drug, Takeda's ...  Oct 16, 2006
...research and advisory firms for pharmaceutical and healthcare issues, finds that, despite a benign safety profile, Takeda's Rozerem (ramelteon), the first ... -PR Newswire (press release), No Dosage Adjustments Required When Coadministering Sertraline and ...  Sep 18, 2006
Depressed patients taking the selective serotonin-reuptake inhibitor (SSRI) sertraline may be safely coadministered the chronohypnotic ramelteon to combat ... -DG News

InfoMedics and Takeda Pharmaceuticals to Co-Present Case Study on ...  Sep 22, 2006
...for the development and execution of personal and non-personal promotional materials, needed to support the promotion of ROZEREM™ (ramelteon), a treatment ... -PharmaLive.com

Side effects you don't hear about  Sep 10, 2006
Although far from side-effect-free, newer drugs such as Ambien (zolpidem), Lunesta (eszopiclone), Rozerem (ramelteon) and Sonata (zaleplon) have been ... -Seattle Times

Insomnia Agents Claimed 82% of Sales for the Sleeping Disorders ...  Sep 4, 2006
Zolpidem has maintained its position despite the launch of two new agents, eszopiclone (Sepracor's Lunesta) and ramelteon (Takeda's Rozerem). ... -Genetic Engineering News

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)...has not included a restriction limiting treatment of insomnia to short-term use for the last three agents it has approved (eszopiclone, ramelteon, and zolpidem ...

Sleep with Rozerem medication  -  Nov 27, 2006
Free press releases (press release),Rozerem with the active ingredient of Ramelteon has been found working effectively to treat insomnia amongst adults. Rozerem that ...

Is a sleeping pill best for you?  Aug 28, 2006
Although far from effect-free, newer drugs such as Ambien (zolpidem), Lunesta (eszopiclone), Rozerem (ramelteon) and Sonata (zaleplon) have been prescribed in ... -Daily Breeze

In this report  Aug 24, 2006
Other sleep drugs such as Sonata (zaleplon) and Rozerem (ramelteon) that did not advertise heavily have had relatively small sales. ... -Consumer Reports (subscription)

SLEEP: Rozerem (ramelteon) Found Safe and Effective In Transient ...  Jun 21, 2006
SALT LAKE CITY, June 21 — Rozerem (ramelteon), a melatonin agonist approved a year ago as an unscheduled agent for insomnia, was found both safe and ... -MedPage Today

New sleep medication Ramelteon shows less potential to foster ...  Jun 27, 2006
Laboratory studies of the effects of ramelteon suggest that the drug's targeting of the brain's melatonin receptors rather than its benzodiazepine receptors ... -News-Medical.net



Ramelteon Showed Significant Reduction in Time to Fall Asleep With ...  Apr 10, 2006
SAN DIEGO, CA -- April 10, 2006 -- Results of a sub-analysis from a phase 3 clinical study showed that Rozerem™ (ramelteon) significantly reduced time to ... - DG News

ROZEREM (ramelteon) Showed Significant Reduction in Time to Fall ...  Apr 3, 2006
Results of a sub-analysis from a Phase III clinical study showed that ROZEREMTM (ramelteon) significantly reduced time to fall asleep in adults with chronic ... - eMaxHealth.com

ROZEREM(TM) (Ramelteon) Showed Significant Reduction in Time to ...  Apr 2, 2006
SAN DIEGO, April 2 /PRNewswire/ -- Results of a sub-analysis from a Phase III clinical study showed that ROZEREM(TM) (ramelteon) significantly reduced time to ... - International News Service

ROZEREM(TM) (ramelteon) Showed Significant Reduction in Time to ...  Apr 3, 2006
DIEGO, CA -- (MARKET WIRE) -- 04/03/2006 -- Results of a sub-analysis from a Phase III clinical study showed that ROZEREM™ (ramelteon) significantly reduced ... - Market Wire

ROZEREM™ (ramelteon) showed significant reduction in time to ...  Apr 3, 2006
San Diego– Results of a sub-analysis from a Phase III clinical study showed that ROZEREM TM (ramelteon) significantly reduced time to fall asleep in adults ... - EurekAlert

Ramelteon showed significant reduction in time to fall asleep  Apr 3, 2006
By Takeda Pharmaceuticals North America, Results of a sub-analysis from a Phase III clinical study showed that ROZEREMTM (ramelteon) significantly reduced time ... - RxPG NEWS

ROZEREM™ Can Be A Better Option For Insomnia Patients  Apr 4, 2006
A recent clinical study showed that ROZEREM™ (ramelteon) could be used for treating people suffering from chronic insomnia, as the medication is found to ... - MedIndia

Takeda Submits New Drug Application For Extended-release Type 2 ...  Apr 6, 2006
...levels. The NDA submission represents yet another milestone for Takeda, following the FDA approval of ROZEREMTM(ramelteon). "We ... - Medical News Today

(PRN) - Following Is a Test Release ... [+]  Apr 2, 2006
...(PRN) - ROZEREM(TM) (ramelteon) Showed Significant Reduction in Time to Fall Asleep With No Evidence of Rebound Insomnia or Withdrawal Effects ... [+. ... - Bolsamania.com



From the analyst's couch: Insomnia market  Jan 9, 2006
Although it has only modest efficacy, recently approved ramelteon (Rozerem; Takeda), a selective melatonin MT 1/2 receptor agonist, has a benign safety profile ... - Nature.com (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional